Rizatriptan: a new 5-HT_1B/1D receptor agonist for the treatment of migraine

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.8, Iss.5, 1999-05, pp. : 671-685

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A review of rizatriptan, a quick and consistent 5-HT_1B/1D agonist for the acute treatment of migraine

By Pascual Julio

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 3, 2004-03 ,pp. : 669-677

Informa Healthcare

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Almotriptan, a Serotonin 5-HT 1B/1D Receptor Agonist for the Treatment of Migraine

By McEnroe Janet D. Fleishaker Joseph C.

Clinical Pharmacokinetics, Vol. 44, Iss. 3, 2005-01 ,pp. : 237-246

Adis International

Access to resources Recommend Favorite

Cranial vascular effects of zolmitriptan, a centrally active 5-HT 1B/1D receptor partial agonist for the acute treatment of migraine

By MacLennan S.J. Cambridge D. Whiting M.V. Marston C. Martin G.R.

European Journal of Pharmacology, Vol. 361, Iss. 2, 1998-11 ,pp. : 191-197

Elsevier

Access to resources Recommend Favorite

The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT 1B/1D receptor agonist

By Gupta P. Butler P. Shepperson N.B. McHarg A.

European Journal of Pharmacology, Vol. 398, Iss. 1, 2000-06 ,pp. : 73-81

Elsevier

Access to resources Recommend Favorite

5-HT 1B/D Receptor Antagonists

By Pauwels P.J.

General Pharmacology, Vol. 29, Iss. 3, 1997-09 ,pp. : 293-303

Elsevier

Access to resources Recommend Favorite